Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease
Total 9779 results
-
Rutgers, The State University of New JerseyCompletedMultiple SclerosisUnited States
-
Fondazione Don Carlo Gnocchi OnlusUniversity of Genova; Azienda Sanitaria Locale 3 GenoveseCompleted
-
SanofiCompletedMultiple SclerosisUnited States, France, Canada, Germany, Spain, Finland, Norway
-
Hugo W. Moser Research Institute at Kennedy Krieger...National Multiple Sclerosis SocietyCompletedMultiple SclerosisUnited States
-
Acorda TherapeuticsCompletedMultiple SclerosisUnited States, Canada
-
Vrije Universiteit BrusselUniversity Hospital, Antwerp; Universiteit Antwerpen; Artesis University College...Completed
-
University of NottinghamUnknownMultiple SclerosisUnited Kingdom
-
Newcastle-upon-Tyne Hospitals NHS TrustCompletedMultiple SclerosisUnited Kingdom
-
University of Illinois at Urbana-ChampaignUnknown
-
BayerCompletedMultiple SclerosisBelgium, Italy, Spain, France, Switzerland, Israel, Czech Republic, Canada, Austria, Poland, Germany, Netherlands, United Kingdom, Hungary, Portugal, Finland, Norway, Sweden, Slovenia, Denmark
-
BiogenCompleted
-
Novartis PharmaceuticalsTerminatedMultiple SclerosisBelgium, Spain, Russian Federation, France, Italy, Poland, Sweden, Turkey, Czech Republic, Japan
-
Örebro County CouncilNorrbacka-Eugenia Foundation; Uppsala-Örebro Regional Research CouncilCompletedMultiple SclerosisSweden
-
National Multiple Sclerosis SocietyUnknown
-
Örebro County CouncilNorrbacka-Eugenia Foundation; Uppsala-Örebro Regional Research CouncilCompleted
-
Oregon Health and Science UniversityCompleted
-
University of Dublin, Trinity CollegeCompleted
-
Stony Brook UniversityTeva Pharmaceuticals USACompleted
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Merck KGaA, Darmstadt, GermanyMerck Serono Australia Pty LtdCompleted
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple SclerosisUnited Kingdom
-
BiogenElan PharmaceuticalsCompleted
-
Fondazione Don Carlo Gnocchi OnlusCompletedMultiple SclerosisItaly
-
Samuel Forrester Hunter, MD, PhDUnknownMultiple SclerosisUnited States
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple SclerosisKorea, Republic of
-
Merck KGaA, Darmstadt, GermanyMerck Serono Limited, UKCompletedMultiple Sclerosis
-
Albert SaizInstituto de Salud Carlos IIITerminated
-
Merck KGaA, Darmstadt, GermanyMerck Serono Limited, UKCompleted
-
University Hospital of FerraraAzienda Ospedaliero, Universitaria PisanaCompleted
-
Ziv HospitalUnknownMultiple SclerosisIsrael
-
Seah Lim M.D.TerminatedMultiple SclerosisUnited States
-
Rutgers, The State University of New JerseyCompletedMultiple SclerosisUnited States
-
EMD SeronoCompleted12-week Study to Evaluate RebiSmart™ Suitability for Self Injection in Relapsing Multiple Sclerosis.Multiple SclerosisUnited States, Canada, Germany, Italy, Spain, Sweden
-
Acorda TherapeuticsPrometrika, LLC; BCS Consulting, Inc.Completed
-
Kessler FoundationNational Multiple Sclerosis SocietyCompleted
-
US Department of Veterans AffairsTerminated
-
BiogenCompleted
-
Teva Branded Pharmaceutical Products R&D, Inc.Withdrawn
-
EMD SeronoCompletedMultiple SclerosisUnited States
-
EMD SeronoCompletedMultiple SclerosisUnited States
-
Louisiana State University Health Sciences Center...National Center for Complementary and Integrative Health (NCCIH)Completed
-
Kessler FoundationEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
Mazandaran University of Medical SciencesUnknown
-
AlJohara M AlQuaiz, M.D.UnknownMultiple SclerosisSaudi Arabia
-
Aaron BosterPfizer; EMD SeronoCompleted
-
Hasselt UniversityKU Leuven; Provinciale Hogeschool LimburgTerminated
-
University of NottinghamWithdrawnMultiple SclerosisUnited Kingdom
-
Sharon Lynch, MDEMD SeronoCompleted
-
BayerCompletedMultiple SclerosisSwitzerland, Poland, France, Germany, Hungary, Spain, Sweden, Austria, Czech Republic, Italy, Slovenia, Israel, Belgium, Denmark, Netherlands, Canada, Norway, Finland
-
Acorda TherapeuticsCompleted